(Q34404469)

2 August 2017

1 reference

title

Erythrocyte-active agents and treatment of sickle cell disease (English)

1 reference

2 August 2017

0 references

Brugnara C

1

1 reference

2 August 2017

De Franceschi L

series ordinal

2

1 reference

2 August 2017

Beuzard Y

series ordinal

3

1 reference

2 August 2017

publication date

1 October 2001

1 reference

2 August 2017

published in

Seminars in Hematology

1 reference

2 August 2017

volume

38

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

324-332

1 reference

How Allosteric Effectors Can Bind to the Same Protein Residue and Produce Opposite Shifts in the Allosteric Equilibrium

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Modification of sickle hemoglobin by acetaldehyde and its effect on oxygenation, gelation and sickling

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Covalent binding of poly(ethylene glycol) (PEG) to the surface of red blood cells inhibits aggregation and reduces low shear blood viscosity.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Tucaresol increases oxygen affinity and reduces haemolysis in subjects with sickle cell anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

The feasibility of pharmacological volume control of sickle cells is dependent on the quantization of the transport pathways. A model study

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Treatment with NS3623, a novel Cl-conductance blocker, ameliorates erythrocyte dehydration in transgenic SAD mice: a possible new therapeutic approach for sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Effect of cetiedil, an in vitro antisickling agent, on erythrocyte membrane cation permeability

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

The effect of methemoglobin formation in sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

The molecular pathobiology of cell membrane iron: the sickle red cell as a model

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Regulation of erythrocyte cation and water content in sickle cell anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Inhibition of Ca(2+)-dependent K+ transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Regulation of cation content and cell volume in hemoglobin erythrocytes from patients with homozygous hemoglobin C disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Pathogenesis and treatment of sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Inhibition of sickling by methyl acetimidate

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Mechanism for the increase in solubility of deoxyhemoglobin S due to cross-linking the beta chains between lysine-82 beta 1 and lysine-82 beta 2

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Sickle-cell anemia: molecular and cellular bases of therapeutic approaches (first of three parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Hematologic and clinical responses in patients with sickle cell anemia after chronic extracorporeal red cell carbamylation

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Oral magnesium supplements reduce erythrocyte dehydration in patients with sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Oral magnesium pidolate: effects of long-term administration in patients with sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Treatment with oral clotrimazole blocks Ca(2+)-activated K+ transport and reverses erythrocyte dehydration in transgenic SAD mice. A model for therapy of sickle cell disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

The function of calcium in the potassium permeability of human erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Sodium cyanate as a potential treatment for sickle-cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Inhaled nitric oxide augments nitric oxide transport on sickle cell hemoglobin without affecting oxygen affinity

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Low concentrations of nitric oxide increase oxygen affinity of sickle erythrocytes in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Hydroxyurea therapy decreases the in vitro adhesion of sickle erythrocytes to thrombospondin and laminin

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Effect of nitric oxide and nitric oxide donors on red blood cell oxygen transport

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Nitric oxide-mediated heme oxidation and selective beta-globin nitrosation of hemoglobin from normal and sickle erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Cation transport and volume regulation in sickle red blood cells

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Deoxygenation-induced cation fluxes in sickle cells. IV. Modulation by external calcium

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Deoxygenation-induced cation fluxes in sickle cells. III. Cation selectivity and response to pH and membrane potential

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Cation depletion by the sodium pump in red cells with pathologic cation leaks. Sickle cells and xerocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Pharmacological modification of oxygen affinity improves deformability of deoxygenated sickle erythrocytes: a possible therapeutic approach to sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Inhibition of plasma-mediated adherence of sickle erythrocytes to microvascular endothelium by conformationally constrained RGD-containing peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Antioxidants in sickle cell disease: the in vitro effects of ascorbic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Compartmentalization of sickle-cell calcium in endocytic inside-out vesicles

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Stochastic nature and red cell population distribution of the sickling-induced Ca2+ permeability

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Nitric oxide metabolite levels in acute vaso-occlusive sickle-cell crisis

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Irreversible deformation of the spectrin-actin lattice in irreversibly sickled cells

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Potential therapeutic applications of fructose-1,6-diphosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Molecular mechanism of red cell "sickling"

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Oral L-glutamine therapy for sickle cell anemia: I. Subjective clinical improvement and favorable change in red cell NAD redox potential

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Intracellular polymerization. Disease severity and therapeutic predictions

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Inhibition of the in vitro formation of irreversibly sickled cells by cepharanthine

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Nitrendipine, nifedipine and verapamil inhibit the in vitro formation of irreversibly sickled cells

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

The mechanism of in vitro formation of irreversibly sickled cells and modes of action of its inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Inhibition of the in vitro formation of dense cells and of irreversibly sickled cells by charybdotoxin, a specific inhibitor of calcium-activated potassium efflux

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Deoxygenation permeabilizes sickle cell anaemia red cells to magnesium and reverses its gradient in the dense cells

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

DEPRESSANT EFFECTS OF HIGH CONCENTRATIONS OF INSPIRED OXYGEN ON ERYTHROCYTOGENESIS. OBSERVATIONS ON PATIENTS WITH SICKLE CELL ANEMIA WITH A DESCRIPTION OF THE OBSERVED TOXIC MANIFESTATIONS OF OXYGEN.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Therapeutic potentiation of the immune system by costimulatory Schiff-base-forming drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

A Study of Induced Hyponatremia in the Prevention and Treatment of Sickle-Cell Crisis

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Peroxidative damage in sickle-cell erythrocyte ghosts: protective effect of allopurinol

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Potassium and sodium of red blood cells in sickle cell anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Basal cell adhesion molecule/lutheran protein. The receptor critical for sickle cell adhesion to laminin.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Thiol compounds as protective agents in erythrocytes under oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

Crystal structure of sickle-cell deoxyhemoglobin at 5 A resolution.

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990026-5

7 January 2021

10.1016/S0037-1963(01)90026-5

Identifiers

DOI

1 reference

2 August 2017

1 reference